{"id":"tp-53072","type":"article-newspaper","title":"Eli Lilly’s Foundayo Cuts Sleep Apnea Events in Two Phase 3 Trials","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/53072","datePublished":"2026-11-10T12:23:50.000Z","dateModified":"2026-11-10T12:23:50.000Z","language":"en","abstract":"The 712-person studies found fewer breathing interruptions at week 52 with the pill than placebo, with or without positive airway pressure therapy. Lilly plans to submit the results to the FDA by year-end.","section":"Business","references":[]}